Document is current
Any future updates will be listed below
-
Authors
Zhang, Di
Rubio Rodríguez-Kirby, Leslie A.
Lin, Yingxin https://orcid.org/0000-0002-4299-7326
Wang, Wenqi
Song, Mengyi
Wang, Li https://orcid.org/0000-0001-9510-6294
Wang, Lijun https://orcid.org/0000-0001-5222-4506
Kanatani, Shigeaki https://orcid.org/0000-0003-2226-4288
Jimenez-Beristain, Tony https://orcid.org/0009-0005-3756-3354
Dang, Yonglong https://orcid.org/0000-0001-9705-5507
Zhong, Mei https://orcid.org/0000-0003-1230-0775
Kukanja, Petra https://orcid.org/0000-0003-1228-5923
Bao, Shuozhen https://orcid.org/0000-0002-9301-9952
Wang, Shaohui
Chen, Xinyi Lisa https://orcid.org/0009-0008-8812-9189
Gao, Fu
Wang, Dejiang
Xu, Hang
Ma, Cong
Lou, Xing
Liu, Yang https://orcid.org/0000-0003-1830-948X
Chen, Jinmiao
Sestan, Nenad https://orcid.org/0000-0003-0966-9619
Uhlén, Per https://orcid.org/0000-0003-1446-1062
Kriegstein, Arnold https://orcid.org/0000-0001-5742-2990
Zhao, Hongyu https://orcid.org/0000-0003-1195-9607
Castelo-Branco, Gonçalo https://orcid.org/0000-0003-2247-9393
Fan, Rong https://orcid.org/0000-0001-7805-8059
- License Information
-
More Information
Article History
Received: 27 July 2024
Accepted: 22 September 2025
First Online: 5 November 2025
Competing interests
: R.F. is a scientific founder and advisor of IsoPlexis, Singleron Biotechnologies and AtlasXomics. The interests of R.F. were reviewed and managed by Yale University Provost’s Office in accordance with the University’s conflict of interest policies. G.C.-B. is shareholder and board member of Nexus Epigenomics. The other authors declare no competing interests.
